VVUS VIVUS Inc.

3.21
-0.23  -7%
Previous Close 3.44
Open 3.47
Price To Book -0.65
Market Cap 34,163,109
Shares 10,642,713
Volume 8,784
Short Ratio
Av. Daily Volume 23,475

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved July 17, 2012.
Qnexa
Obesity
Approved Apr 27 2012. sNDA label change also approved 17 Sept 2014
Avanafil
Erectile dysfunction
Phase 1 trial completed July 2018.
VI-0106
Pulmonary arterial hypertension (PAH)

Latest News

  1. Edited Transcript of VVUS earnings conference call or presentation 6-Aug-19 8:30pm GMT
  2. Could The VIVUS, Inc. (NASDAQ:VVUS) Ownership Structure Tell Us Something Useful?
  3. VIVUS Reports Second Quarter 2019 Financial Results.
  4. VVUS: Qsymia Receives Approval in Korea
  5. VIVUS Announces Approval of Qsymia® in the Republic of Korea
  6. VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019
  7. VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current and Future Demand for PANCREAZE®
  8. Does The VIVUS, Inc. (NASDAQ:VVUS) Share Price Fall With The Market?
  9. VIVUS Reduces Barrier to Achieving Healthy Weight Goals With Launch of Online Platform to Purchase Qsymia®
  10. VVUS: Qsymia Receives an FDA Letter
  11. VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents
  12. VIVUS Partners with HarborPath Direct to Facilitate Access to PANCREAZE® for Patients Without Health Insurance
  13. VVUS: New Ideas for Established Portfolio
  14. Edited Transcript of VVUS earnings conference call or presentation 30-Apr-19 8:30pm GMT
  15. Vivus: 1Q Earnings Snapshot
  16. VIVUS Reports First Quarter 2019 Financial Results
  17. If You Had Bought VIVUS (NASDAQ:VVUS) Stock Five Years Ago, You'd Be Sitting On A 93% Loss, Today
  18. VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, April 30, 2019
  19. VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction